文献速递神经肿瘤

成人及儿童H3 K27M突变型弥漫性中线胶质瘤的临床、影像与分子特征比较

Diffuse midline glioma with H3 K27M mutation: a comparison integrating the clinical, radiological, and molecular features between adult and pediatric patients.
PubMed 文献 · Neuro Oncol · 2020-01-01

儿童组术前KPS更低、全切除率更低、肿瘤更大、Ki-67指数更高,术后颅神经麻痹和共济失调发生率更高,成人好发于丘脑而儿童好发于脑干;成人及儿童中位生存分别为16.0个月和10.0个月,差异显著。多因素分析确认诊断年龄、放疗和运动障碍为独立预后因素,放疗与延长生存独立相关。

要点

  • 儿童H3 K27M突变型DMG较成人全切除率更低、Ki-67更高、术后神经功能缺损更多。
  • 成人DMG好发于丘脑,儿童好发于脑干,中位生存分别为16.0和10.0个月。
  • 放疗是延长生存的独立因素,诊断年龄和运动障碍亦为独立预后因素。

核心结论

  • 儿童H3 K27M突变型DMG具有独特的临床、影像和分子特征,预后较成人更差。
  • 放疗是与延长生存独立相关的因素。

研究设计与样本

  • 按年龄分为成人组57例(49.1%)和儿童组59例(50.9%),比较临床、影像和分子特征。
  • 采用单因素和多因素分析识别预后因素。

主要发现

  • 儿童组较成人组年龄更小(8.9±4.1岁 vs 35.1±11.8岁,P<0.001)。
  • 儿童组术前KPS更低(62.9±15.5 vs 72.1±16.5,P=0.004),全切除率更低(5.7% vs 26.8%,P=0.009)。
  • 儿童组肿瘤更大(4.4±0.9 vs 3.9±1.5 cm,P=0.045),Ki-67指数更高(63.0% vs 37.8%,P=0.047)。
  • 儿童组术后颅神经麻痹(61.0% vs 36.8%,P=0.009)和共济失调(45.8% vs 26.3%,P=0.029)发生率更高。
  • 成人DMG主要位于丘脑,儿童主要位于脑干(P<0.001),成人及儿童中位生存分别为16.0(9.7-22.3)个月和10.0(8.3-11.7)个月(P=0.008)。

关键数值与推荐

  • 多因素分析显示诊断年龄、放疗和运动障碍为独立预后因素(P<0.05)。

临床怎么用

  • 儿童H3 K27M突变型DMG术后神经功能缺损风险较高,需加强围手术期管理。
  • 放疗应作为延长生存的重要治疗手段。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Diffuse midline glioma (DMG), H3 K27M mutant, occurs in both adult and pediatric populations. The characteristics of the 2 DMG groups were systematically explored in this study. METHODS: H3 K27M-mutant DMG was diagnosed in 116 patients at Beijing Tiantan Hospital from May 2016 to December 2018 who were included in our study. Patients were classified into an adult group (n = 57; 49.1%) and a pediatric group (n = 59; 50.9%). Clinical, radiological, and molecular features were compared between the groups. Univariate and multivariate analyses were performed to identify prognostic factors. RESULTS: Compared with the adult group, pediatric patients had a younger age (8.9 ± 4.1 y vs 35.1 ± 11.8 y, P < 0.001), a lower preoperative Karnofsky performance scale score (62.9 ± 15.5 vs 72.1 ± 16.5, P = 0.004), a lower rate of total resection (5.7% vs 26.8%, P = 0.009), a larger tumor size (4.4 ± 0.9 vs 3.9 ± 1.5 cm, P = 0.045), a higher Ki-67 index (63.0% vs 37.8%, P = 0.047), and higher rates of postoperative cranial nerve palsy (61.0% vs 36.8%, P = 0.009) and ataxia (45.8% vs 26.3%, P = 0.029). Adult DMG was located predominantly in the thalamus, while the predilection site for pediatric DMG was brainstem (P < 0.001). Kaplan-Meier plot showed that the median survival of adult and pediatric DMG was 16.0 (9.7-22.3) months and 10.0 (8.3-11.7) months, respectively, which imparted a significant difference (P = 0.008). Age at diagnosis, radiotherapy, and motor deficit were confirmed as independent prognostic factors according to the multivariate analysis (P < 0.05). CONCLUSION: Compared with adult patients, children with H3 K27M-mutant DMG confer distinct clinical, radiological, and molecular characteristics and have a dismal prognosis. Radiotherapy is an independent factor associated with prolonged survival.

来源:Neuro Oncol,查看原文。版权归原作者所有。

引用

  1. Jiang H, Yang K, Ren X, et al. Diffuse midline glioma with H3 K27M mutation: a comparison integrating the clinical, radiological, and molecular features between adult and pediatric patients. Neuro Oncol. 2020. PMID: 31504810. doi:10.1093/neuonc/noz152

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。